SCHEMBL722489

SCHEMBL722489

C=CC(C)(O)CCCC(C)C

nearest known ligand 0.85

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.85
MEN1 O00255 1/20 0.85
CYP3A4 P08684 1/20 0.85
KMT2A Q03164 1/20 0.85
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
CDC25B P30305 1/20 0.35
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30492702 1.00 ALOX15 (0.85) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL29069355 0.98 ALOX15 (0.81) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL28826305 0.98 ALOX15 (0.81) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL27456678 0.98 ALOX15 (0.81) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL27963124 0.98 ALOX15 (0.81) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL4437129 0.92 ALOX15 (1.00) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL8079400 0.92 ALOX15 (1.00) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL8082488 0.92 ALOX15 (1.00) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL29659795 0.92 ALOX15 (1.00) ALOX15MEN1CYP3A4KMT2APTPN2
SCHEMBL15824175 0.92 ALOX15 (1.00) ALOX15MEN1CYP3A4KMT2APTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12580195-B2 Lithium-ion secondary battery SAFT AMERICA (US) 2026-03-17 US claimed
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol GLYCOSCIENCE, S.L. (ES) 2025-12-30 US claimed
US-20250134790-A1 ANTIMICROBIAL COMPOSITIONS FIRMENICH SA (CH) 2025-05-01 US claimed
EP-4387583-A1 ANTIMICROBIAL COMPOSITIONS Firmenich SA (CH) 2024-06-26 EP claimed
CN-117881386-A Antimicrobial compositions 弗门尼舍有限公司 2024-04-12 CN claimed
CN-116462578-B Method for synthesizing delta-methyl ketone by one-pot method 万华化学集团股份有限公司 2024-04-09 CN claimed
WO-2023247604-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN FIRMENICH SA (CH) 2023-12-28 WO claimed
US-20230392098-A1 IMPROVED FRESHNESS IMPARTING COMPOSITIONS FIRMENICH SA (CH) 2023-12-07 US claimed
US-20230327111-A1 LITHIUM-ION SECONDARY BATTERY SAFT AMERICA (US) 2023-10-12 US claimed
CN-116462578-A Method for synthesizing delta-methyl ketone by one-pot method 万华化学集团股份有限公司 2023-07-21 CN claimed
US-6051741-A REACTING AN ALLYL ALCOHOL WITH DIKETENE OR ALKYL ACETOACETATE IN THE PRESENCE OF ALUMINUM ALCOHOLATE CATALYST BASF AKTIENGESELLSCHAFT (DE) 2000-04-18 US claimed
WO-2000014046-A1 METHOD FOR PRODUCING η,δ-UNSATURATED KETONES BY CARROLL-REACTION BASF AKTIENGESELLSCHAFT (DE) 2000-03-16 WO claimed
EP-0754664-B1 Process for preparing alkenes by partial hydrogenation of alkines on solid-bed-palladium-catalysts BASF AG (DE) 1999-11-17 EP claimed
CN-1218792-A Process for preparing gamma, delta unsaturated ketone by carroll reaction and novel catalyst used in said method and its preparation BASF AG (DE) 1999-06-09 CN claimed
CN-1217316-A Preparation for unsaturated ketone BASF AG (DE) 1999-05-26 CN claimed
EP-0909750-A1 Process for the preparation of gamma, delta-unsaturated ketones ba Carroll-reaciton, catalysts for this process and their preparation BASF AKTIENGESELLSCHAFT (DE) 1999-04-21 EP claimed
EP-0902001-A1 Process for the preparation of unsaturated ketones BASF AKTIENGESELLSCHAFT (DE) 1999-03-17 EP claimed
US-5750806-A Preparation of alkenes by partial hydrogenation of alkynes over fixed-bed palladium catalysts BASF AKTIENGESELLSCHAFT (DE) 1998-05-12 US claimed
EP-0816321-A1 Process for producing 6-methyl-3-hepten-2-one and 6-methyl-2-heptanone analogues, and process for producing phyton or isophytol KURARAY CO., LTD. (JP) 1998-01-07 EP claimed
EP-0754664-A2 Process for preparing alkenes by partial hydrogenation of alkines an solid-bed-palladium-catalysts BASF AKTIENGESELLSCHAFT (DE) 1997-01-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509482-B2 3′-ketoglycoside compound for the slow release of a volatile alcohol EBP, MGAT1, MGAT3 ALOX15 3075/4885MEN1 3970/4885CYP3A4 1704/4885
US-12580195-B2 Lithium-ion secondary battery H1-0, COG8, BET1 ALOX15 3094/4885MEN1 1591/4885CYP3A4 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.